An expert discusses how medical professionals counsel eligible patients about adjuvant immune checkpoint inhibitor (ICI) ...

An expert discusses how the availability of subcutaneous (SC) immune checkpoint inhibitors (ICI) for bladder cancer impacts ...

Policy proposal offers recommendations on dual-share class funds, semi-transparent ETFs, and expanded flexibility for ...

The slowdown of growth in the fourth quarter does not imply there is dwindling demand for munis, said Pat Luby, head of ...

EDITORIAL. With its massive bombardment of the Gaza Strip on Tuesday, despite the ceasefire, the Israeli government is ...

The single currency has returned to its highest level since the election of the US president in November 2024 and is ...

The White House responded by saying that “it's only because of the United States of America that the French are not speaking ...

In Goma, families deprived of their homes and livelihoods often wander in search of refuge, not knowing what tomorrow will ...

Patients receiving ICIs were associated with a greater risk of developing RA, but lower risks for SLE and SSc.

Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...

This comes ten months after the firm announced that it had secured $150 million in funding comprised of a revolving credit ...

Chronic cutaneous adverse events affected 8% of patients after checkpoint inhibitor therapy in a cohort study, often ...